Questions discussed in this category
	
        	
	
	If a patient clearly has N1 disease with high SUV on PET, do you routinely recommend EBUS or mediastinoscopy to evaluate for N2 disease?
 
        	
	
	Does it factor into your decision making in the setting of restricted spirometry and normal lung volumes? Does this differ for SBRT v. chemoRT?
 
 
5158429272254356
 
Papers discussed in this category
	Int. J. Radiat. Oncol. Biol. Phys., 2010-06-01
Thorac Cancer, 2017 Apr 24
International journal of radiation oncology, biology, physics, 2013-03-01
Respir. Res., 2018 Apr 24